I’m a Celebrity Diagnosis, Get Me a Teachable Moment



By Kevin Davies

June 25, 2009 | Combining teachable moments with the power of celebrity, a husband-and-wife team of physicians in Boston has launched an informative and engaging new web resource and blog called CelebrityDiagnosis.com.

The idea to provide accurate and actionable medical information by capitalizing on the media’s fascination with everything celebrity belongs to Michele Berman, a retired pediatrician. Berman developed one of the first medical practice websites in 1997 and has experience writing columns for consumers for parenting magazines. Her husband is Mark Boguski, an MD affiliated with Harvard Medical School who recently launched his own health website, Resounding Health. (CelebrityDiagnosis.com was created using Resounding Health tools, Boguski points out.) A leading bioinformatician, Boguski has held senior positions at the NCBI, the Allen Brain Institute, and Novartis, and is a past Bio-IT World Expo keynote speaker, before branching out into web development.

The idea of CelebrityDiagnosis.com, according to Boguski, is to capitalize on the educational possibilities of medical information while it is in the news. “In medicine, when you’re training, you’re doing rounds on patients. When you’re a student, you have textbook and theoretical knowledge of the disease. But there’s a phenomenon called a ‘teachable moment’ in medicine, when you encounter a patient with an absolute textbook case of a disease and that becomes a time to transform book learning into tangible lessons that will last a lifetime,” Boguski told Bio-IT World.

Boguski continued: “It’s been thought in the past that teachable moments are fortuitous and unpredictable, but we feel that we can create a serial collection of teachable moments designed to inform consumers about their health and medical matters.”

Power of Celebrity

The power of celebrities to change medical thinking and funding is profound. Former First Lady Betty Ford’s discovery of breast cancer in 1974 and subsequent surgery immediately raised awareness of the toll caused by the disease, and led to significant increases in funding. Nancy Reagan’s diagnosis in 1987 was another major turning point, almost overnight triggering waves of volunteers that helped lead to the mapping of BRCA1 in 1990.

In other fields, one thinks of Michael J. Fox and Parkinson’s disease; President Ronald Reagan and Alzheimer’s disease; Michael Milken and prostate cancer; Lance Armstrong and testicular cancer, Freddie Mercury, Earvin Johnson and AIDS; and Stephen Hawking and ALS. Just this week, one of the Jonas brothers was testifying on Capitol Hill on behalf of type 1 diabetes research.

Berman and Boguski hope that CelebrityDiagnosis.com provides a richer vein of knowledge for the general public. The website publishes information on diseases and other conditions in the news, focusing on what the creators call “uncommon people from the worlds of entertainment, sports, business, government and politics, science and technology who suffer from medical conditions that do not respect fame or fortune and that can affect anyone.” In a statement, Esther Dyson, a healthcare investor in companies such as 23andMe, said: “I'm in favor of anything that will attract people's attention and give them some serious information along with the fluff.”

Casebooks contain authoritative information that can be forwarded and linked, even taken to appointments with a family physician. Examples include cancer, heart disease, anxiety, depression, Alzheimer's, accidental death and alternative medicine. Among the celebrities featured already – from D List actresses to Supreme Court Justices -- are: Elizabeth Hasselbeck, Ruth Bader Ginsburg, Bret Michaels, Susan Boyle, Natalie Cole, Lisa Rinna, Sergey Brin and Steve Jobs. In the past 48 hours, posts have featured the late Jerri Nielsen and David Carradine.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .